IP Verse

Insulin Formulations For Rapid Uptake - EP3372238B1

PatentPatent Analysis

EP3372238

ELI LILLY
Application Number
EP18155633A
Filing Date
Mar 3, 2010
Status
Granted And Under Opposition
Oct 16, 2020
Grant Date
Nov 18, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2247558B2
EP3668568B1
EP3432949B1

Bibliography

The patent EP3372238B1 was granted to ELI Lilly on Nov 18, 2020 following the initial filing on Mar 3, 2010 under the application number EP18155633A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BOHMANNAug 17, 2021ADMISSIBLE
SCORPIOAug 16, 2021ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents